I received my urologic training in the 1990s, when most major urologic procedures were performed using a traditional open surgical technique, and when the mantra was “big surgery, big incision.” It was here that my passion began for finding a better, less-invasive surgical approach to perform these complex procedures.
Soon after completing a minimally invasive fellowship in urology and joining NYU Langone, I was introduced to robotic-assisted surgery, and it was immediately obvious to me that by employing this technology, my goals would be realized. By embracing the technology early, I have performed more robotic partial nephrectomies and upper urinary tract reconstructions than any surgeon in New York City, and am now one of the top 10 urologists in the city performing robotic prostate removal, known as prostatectomy.
Equally important to me is providing the most personalized and highest quality approach to each individual’s condition or disease. This includes spending time with each of my patients in order to understand their concerns and to make sure all their questions are answered, so that they are full partners in the decision and treatment process.
As the inaugural director of NYU Langone’s Robotic Surgery Center, I’ve worked to build a world-class multidisciplinary center of excellence. Since the program’s establishment in 2008, it has grown to become the premier academic multispecialty robotic surgery program in New York City, with more than 25 surgeons practicing across six surgical disciplines and performing more then 1,800 robotic surgeries per year.
My enthusiasm for robotic surgery extends to education and training, and each year I travel nationally and internationally to teach advanced robotic surgical techniques. I am also the director of the NYU Multispecialty Robotic Surgery Course, the largest annual robotic surgery course in New York City.
Since joining NYU Langone, I am proud to have been recognized by Castle Connolly’s New York Top Doctors, America’s Top Doctors, and Top Doctors for Cancer, as well as in New York Magazine’s annual Top Doctors issue. In addition, I have been awarded the Patients’ Choice Award and the Compassionate Doctor Award.
Conditions and Treatments
Show More Conditions
- Professor, Department of Urology
- Dir Min Inv Urology Laparscopy & Robotics
- American Board of Urology - Urology
Education and Training
- Fellowship, Cornell University Medical Center, Urology
- Residency, Columbia-Presbyterian Medical Center, Urology
- MD from Albert Einstein College Of Med
Locations and Appointments
- Aetna HMO
- Aetna Indemnity
- Aetna Medicare
- Aetna POS
- Aetna PPO/EPO
- Affinity Exchange- Essential
- Cigna EPO/POS
- Cigna PPO
- Empire Blue Cross Blue Shield EPO
- Empire Blue Cross Blue Shield HMO
- Empire Blue Cross Blue Shield Healthy NY
- Empire Blue Cross Blue Shield Indemnity
- Empire Blue Cross Blue Shield MediBlue
- Empire Blue Cross Blue Shield POS
- Empire Blue Cross Blue Shield PPO
- Empire Blue Cross Blue Shield Pathways, Enhanced
- HIP Access I
- HIP Access II
- HIP Child Health
- HIP EPO/PPO
- HIP Family Health
- HIP HMO
- HIP Medicaid
- HIP Medicare
- HIP POS
- HealthSmart (WTC)
- Horizon Blue Cross Blue Shield
- Hotel Trades
- Humana Medicare
- Local 1199 PPO
- MagnaCare PPO
- MultiPlan/PHCS PPO
- NYS Empire Plan
- Oxford Exchange
- Oxford Freedom
- Oxford Liberty
- Oxford Medicare
- United Exchange- Compass
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare Medicare
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare Top Tier
My three major areas of research have been the management of kidney cancer, upper urinary tract reconstruction and evaluation of innovative surgical technologies.
My research parallels my clinical focus and expertise which serves as the under pinnings for my academic productivity. To date, these research activities have led to 87 peer reviewed publications, 10 book chapters and 8 review articles and 62 abstracts presented at national and international meetings. I have also created over 30 educational videos, which have been distributed by the American Urologic Association, European Association Urology and World Congress of Endourology and have been awarded First Prize and Top 10 Videos at these society annual meetings.
I recognized early in my career the power of intra and inter departmental and multi-institutional collaboration. Several years ago, I organized the largest robotic partial nephrectomy consortium in the world that includes John Hopkins, Cleveland Clinic, Washington University and Henry Ford Hospital. Together, we have published seminal papers on outcomes following partial robotic nephrectomy for renal cancer. Over the years, I have developed and helped launch multiple IRB databases, protocols and multi-institutional projects that have been the source of several important advances in the field
My three major areas of research have been the management of kidney cancer, upper urinary tract reconstruction and evaluation of innovative surgical technologies. Some of my major accomplishments have been to develop innovative techniques to minimize warm ischemia during partial nephrectomy and novel robotic surgical techniques for upper urinary tract reconstruction. Within the last 5 years I have pioneered two novel techniques that have been adopted by surgeons worldwide. The first uses near infrared fluorescence (NIRF) imaging during robotic surgery to minimize trauma to the kidney during partial nephrectomy and confirm adequate perfusion of tissue during reconstructive surgery. The other utilizes buccal mucosa tissue to replace and repair strictures within the ureter. I have conducted numerous retrospective and prospective outcome studies related to management of kidney cancer and upper tract reconstruction that have helped define optimal management of these conditions. I currently have reported the largest single surgeon series on robotic upper urinary tract reconstruction As a recognized leader in the field of minimally invasive surgery, many companies have engaged me evaluate new technologies designed facilitate minimally invasive surgery.
kidney cancer, prostate cancer, minimally invasive surgery, robotic surgery, urinary tract reconstruction
Near-infrared fluorescence imaging with intraoperative administration of indocyanine green for robotic partial nephrectomyBjurlin, Marc A; McClintock, Tyler R; Stifelman, Michael D 2015 Apr; 495-495, Current urology reports — id: 1473192, year: 2015, page: 495, stat: Journal Article
Outcomes of Robotic-Assisted Laparoscopic Upper Urinary Tract Reconstruction: 250 Consecutive PatientsMarien, Tracy; Bjurlin, Marc; Wynia, Blake; Bilbily, Matthew; Rao, Gaurav; Zhao, Lee C; Shah, Ojas; Stifelman, Michael D 2015 Feb; 277-284, BJU international — id: 1465882, year: 2015, page: 277, stat: JOURNAL ARTICLE
Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing NephrectomyRamaswamy, K; Kheterpal, E; Pham, H; Mohan, S; Stifelman, M; Taneja, S; Huang, WC 2015; -, Clinical genitourinary cancer — id: 1524112, year: 2015